Bacterial endotoxin acceptance limits depend on the device’s intended use, the type of patient contact, and applicable regulatory requirements.
FDA guidance identifies commonly applied limits for certain medical device categories:
- Cardiovascular and Lymphatic Contact: 20 endotoxin units (EU) per device or 0.5 EU/mL of extract under specified extraction conditions.
Cerebrospinal Fluid Contact: 2.15 EU/device or 0.06 EU/mL of extract under specified extraction conditions. Devices intended for intraocular use may have different, more stringent requirements.
These values are not universal limits for all medical devices. Appropriate acceptance criteria must consider the device’s intended use, extraction conditions, applicable standards, and regulatory expectations.
Working with an experienced analytical testing laboratory can help manufacturers select suitable methods and evaluate results against the appropriate specifications.
